Evidence map›Paper›PMID 22382926›Full record

ReviewCellular and molecular life sciences : CMLS2012

Sex chromosome inactivation in germ cells: emerging roles of DNA damage response pathways.

Yosuke Ichijima, Ho-Su Sin, Satoshi H Namekawa

Abstract readReview
In one paragraph

Review in Cellular and molecular life sciences : CMLS, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Epigenetics drive the evolution of sex chromosomes in animals and plants.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2021
    Review
  19. Article
  20. Meiotic Chromosome Synapsis and XY-Body FormationFrontiers in endocrinology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Yosuke IchijimaDivision of Reproductive Sciences, Perinatal Institute, Cincinnati Children's Hospital Medical Center, Department of Pediatrics, University of Cincinnati College of Medicine, OH, USA.
Ho-Su Sin
Satoshi H Namekawa

Funding

DNA Damage Response Pathways in Meiotic Sex Chromosome InactivationR01GM098605 · NIGMS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI NAMEKAWA, SATOSHI · 2011 to 2020
$3.3M
NIGMS NIH HHS GM098605NIGMS NIH HHS R01 GM098605
6 · The paper itself

Abstract

Sex chromosome inactivation in male germ cells is a paradigm of epigenetic programming during sexual reproduction. Recent progress has revealed the underlying mechanisms of sex chromosome inactivation in male meiosis. The trigger of chromosome-wide silencing is activation of the DNA damage response (DDR) pathway, which is centered on the mediator of DNA damage checkpoint 1 (MDC1), a binding partner of phosphorylated histone H2AX (γH2AX). This DDR pathway shares features with the somatic DDR pathway recognizing DNA replication stress in the S phase. Additionally, it is likely to be distinct from the DDR pathway that recognizes meiosis-specific double-strand breaks. This review article extensively discusses the underlying mechanism of sex chromosome inactivation.

Indexed as

Adaptor Proteins, Signal TransducingAnimalsCell Cycle ProteinsDNA DamageDNA RepairEpigenesis, GeneticFemaleGerm CellsHistonesHumansIntracellular Signaling Peptides and ProteinsMaleMeiosisModels, BiologicalModels, GeneticSignal TransductionAdaptor Proteins, Signal TransducingCell Cycle ProteinsHistonesIntracellular Signaling Peptides and ProteinsMDC1 protein, mouse

Identifiers

PMID22382926
PMCPMC3744831

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.